Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 298 entries
View as:

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Phase: N/A Priority: Normal
NCT ID: NCT03556904 Org: User:
Start: 12/10/18 End: 07/28/23 Due: 07/28/24

Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02946008 Org: User:
Start: 03/27/17 End: 07/12/19 Due: 07/12/20

Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program

Phase: N/A Priority: Normal
NCT ID: NCT04616651 Org: User:
Start: 03/25/21 End: 08/10/21 Due: 08/10/22

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Phase: N/A Priority: Normal
NCT ID: NCT03787680 Org: User:
Start: 10/31/19 End: 08/31/28 Due: 08/31/29

Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT00148109 Org: User:
Start: 06/30/05 End: 12/31/09 Due: 12/31/10

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00161265 Org: User:
Start: 05/31/05 End: 06/30/16 Due: 06/30/17

Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC

Phase: N/A Priority: Normal
NCT ID: NCT00616109 Org: User:
Start: 09/30/07 End: 01/31/11 Due: 01/31/12

Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling

Phase: N/A Priority: Normal
NCT ID: NCT00161278 Org: User:
Start: 12/31/04 End: 08/31/06 Due: 08/31/07

Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03927105 Org: User:
Start: 04/25/19 End: 07/06/23 Due: 07/06/24

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03194373 Org: User:
Start: 10/12/17 End: 03/17/20 Due: 03/17/21

Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03287050 Org: User:
Start: 01/24/18 End: 11/10/20 Due: 11/10/21

Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine

Phase: N/A Priority: Normal
NCT ID: NCT00156312 Org: User:
Start: 07/31/03 End: 02/28/07 Due: 02/28/08

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00150995 Org: User:
Start: 05/31/01 End: 04/30/06 Due: 04/30/07

Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01663246 Org: User:
Start: 04/30/06 End: 12/31/08 Due: 12/31/09

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06356155 Org: User:
Start: 06/30/25 End: 03/31/28 Due: 03/31/29

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06616155 Org: User:
Start: 07/30/25 End: 07/30/29 Due: 07/30/30

A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01409681 Org: User:
Start: 05/31/11 End: 12/31/13 Due: 12/31/14

Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02138578 Org: User:
Start: 05/31/14 End: 02/28/17 Due: 02/28/18

Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus

Phase: N/A Priority: Normal
NCT ID: NCT00239200 Org: User:
Start: 10/31/05 End: 09/30/07 Due: 09/30/08

Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04845035 Org: User:
Start: 01/31/24 End: 01/31/29 Due: 01/31/30

Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00967824 Org: User:
Start: 10/31/05 End: - Due: -

A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML

Phase: N/A Priority: Normal
NCT ID: NCT02973711 Org: User:
Start: 01/31/18 End: 08/31/21 Due: 08/31/22

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04272645 Org: User:
Start: 10/31/20 End: 10/31/22 Due: 10/31/23

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05945121 Org: User:
Start: 08/25/23 End: 08/31/27 Due: 08/31/28

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00593866 Org: User:
Start: 06/30/06 End: 10/31/14 Due: 10/31/15